CD274 and neoplasm: Research in this field has focused primarily on identifying biomarkers in the tumor microenvironment, overcoming immune escape and resistance to optimize efficacy, and reducing adverse effects. Additionally, the integration of artificial intelligence and advanced algorithms offers new potential for immunotherapy, and advancements in science and technology will further support research on PD-1/PD-L1 inhibitor immunotherapy.